Trial intelligence / Profile preview

Pilot study of allogeneic PRP injections for knee osteoarthritis

2021-001267-24Phase 2Active

Sponsor
Arthroscopic Surgery Unit
Start
Jan 2022
Modality
Cell Therapies
Countries
1
01

Overview

Phase 2, single-arm trial of PRGF-Endoret in knee osteoarthritis (OA), sponsored by Arthroscopic Surgery Unit. Primary endpoint: Clinically significant pain improvement according to KOOS scale. Started Jan 2022; status: active.

02

Drugs

PRGF-Endoret
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on 2021-001267-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2021-001267-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call